2-Chloro-5-fluoro-4-iodopyridine

We are 2-Chloro-5-fluoro-4-iodopyridine CAS:884494-49-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Chloro-5-fluoro-4-iodopyridine
CAS.NO:884494-49-9
Synonyms:2-Chloro-5-fluoro-4-iodopyridine
 
Physical and Chemical Properties:
Density 2.1±0.1 g/cm3
Boiling Point 242.2±35.0 °C at 760 mmHg
Molecular Formula C5H2ClFIN
Molecular Weight 257.432
Flash Point 100.3±25.9 °C
 
Specification:
Appearance:white to light yellow crystalline powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2-Chloro-5-fluoro-4-iodopyridine


Related News: It is frequently associated with the presence of blasts or leukemic cells in the marrow.Difenilacetonitrilo CAS:86-29-3 From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.4835-39-6 Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.Anilino-methyl-triethoxysilane Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.”This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.

Related Products
Product Name
p-Dithiane-2,5-diol View Details
Bisoctrizole View Details
Ethyl 3-Bromopropionate View Details
Difurfurylsulfide manufacturer N4,N4,N4′-Triphenyl-[1,1′-biphenyl]-4,4′-diamine manufacturer 2,6-DIFLUOROBENZOTRIFLUORIDE manufacturer (E)-3-(5-nitrocyclohexen-1-yl)prop-2-enoic acid manufacturer 6-bromo-13,13-dimethyl-11-phenyl-13H-indeno[1,2-b]anthracene manufacturer